Pulmonx Corp - COM (LUNG) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / COM
Symbol
LUNG on Nasdaq
Shares outstanding
40,762,262
Price per share
$1.83
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
32,374,685
Total reported value
$71,537,254
% of total 13F portfolios
0%
Share change
+1,187,643
Value change
+$3,232,993
Number of holders
108
Price from insider filings
$1.83
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COM (LUNG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 12% -10% $8,029,839 -$742,073 4,956,691 -8.5% PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
MORGAN STANLEY 8.5% +12% $17,530,110 +$2,200,052 3,390,737 +14% Morgan Stanley 31 Mar 2025
BlackRock, Inc. 6.8% $13,933,140 2,694,998 BlackRock, Inc. 31 Mar 2025
FMR LLC 0.2% -104% $114,736 -$3,416,852 70,825 -97% FMR LLC 31 Oct 2025

As of 31 Dec 2025, 108 institutional investors reported holding 32,374,685 shares of Pulmonx Corp - COM (LUNG). This represents 79% of the company’s total 40,762,262 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Pulmonx Corp - COM (LUNG) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 12% 4,727,791 -4.6% 0.01% $10,448,418
MORGAN STANLEY 10% 4,160,469 +15% 0% $9,194,637
BlackRock, Inc. 6.6% 2,706,190 +1.2% 0% $5,980,680
VANGUARD GROUP INC 6.2% 2,540,535 +13% 0% $5,614,582
Soleus Capital Management, L.P. 5% 2,038,323 0.19% $4,504,694
ExodusPoint Capital Management, LP 4.8% 1,951,173 0.05% $4,312,092
SILVERCREST ASSET MANAGEMENT GROUP LLC 3.1% 1,264,233 0% 0.02% $2,793,955
DEUTSCHE BANK AG\ 2.8% 1,125,861 0% 0% $2,488,152
GEODE CAPITAL MANAGEMENT, LLC 2.2% 906,521 -7.4% 0% $2,003,752
STATE STREET CORP 2% 821,217 +3.6% 0% $1,814,890
BRAIDWELL LP 1.8% 752,541 0% 0.05% $1,663,116
BANK OF AMERICA CORP /DE/ 1.8% 727,799 +52% 0% $1,608,436
Parkman Healthcare Partners LLC 1.8% 727,781 +45% 0.15% $1,608,396
D. E. Shaw & Co., Inc. 1.4% 561,266 -29% 0% $1,240,398
Stonepine Capital Management, LLC 1.2% 486,400 -27% 0.86% $1,074,944
BARCLAYS PLC 1.2% 472,251 +39% 0% $1,043,675
JPMORGAN CHASE & CO 1% 426,779 -14% 0% $943,181
GSA CAPITAL PARTNERS LLP 0.99% 403,762 -47% 0.08% $892,000
GOLDMAN SACHS GROUP INC 0.9% 365,203 -7.5% 0% $807,099
ADAR1 Capital Management, LLC 0.87% 355,410 +66% 0.06% $785,456
NORTHERN TRUST CORP 0.83% 337,129 -7% 0% $745,055
RENAISSANCE TECHNOLOGIES LLC 0.72% 292,000 -12% 0% $645,320
Jefferies Financial Group Inc. 0.7% 285,110 0% 0.01% $630,093
CFM WEALTH PARTNERS LLC 0.65% 264,039 0% 0.08% $583,526
Birchview Capital, LP 0.61% 250,573 0.32% $553,766

Institutional Holders of Pulmonx Corp - COM (LUNG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 32,374,685 $71,537,254 +$3,232,993 $2.21 108
2025 Q3 31,835,122 $51,571,453 -$11,678,469 $1.62 104
2025 Q2 36,256,022 $93,898,311 -$4,596,833 $2.59 113
2025 Q1 36,156,132 $243,324,576 +$1,663,003 $6.73 114
2024 Q4 35,870,967 $243,565,337 +$1,640,704 $6.79 117
2024 Q3 35,563,337 $293,811,542 +$7,857,689 $8.29 112
2024 Q2 34,744,517 $220,280,080 -$2,027,570 $6.34 108
2024 Q1 34,672,382 $321,430,455 +$7,599,744 $9.27 117
2023 Q4 33,520,168 $427,381,569 +$18,995,295 $12.75 122
2023 Q3 33,253,122 $343,505,198 -$6,689,600 $10.33 113
2023 Q2 33,869,172 $443,992,925 -$9,642,079 $13.11 112
2023 Q1 34,707,575 $388,032,205 +$25,513,692 $11.18 101
2022 Q4 33,773,100 $284,706,913 -$83,075,336 $8.43 111
2022 Q3 34,912,391 $581,637,070 -$4,909,166 $16.66 100
2022 Q2 35,341,147 $520,187,047 -$7,902,826 $14.72 102
2022 Q1 34,711,340 $861,059,885 +$56,937,629 $24.81 105
2021 Q4 32,045,807 $1,027,712,027 +$25,949,573 $32.07 108
2021 Q3 31,600,475 $1,136,986,158 +$204,291,164 $35.98 118
2021 Q2 25,771,799 $1,136,970,052 +$216,275,676 $44.12 112
2021 Q1 20,788,776 $950,879,909 +$115,760,357 $45.74 107
2020 Q4 17,288,638 $1,179,671,046 +$1,018,686,046 $69.02 98